Skip to main content
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 1983 Sep;37(3):221–225. doi: 10.1136/jech.37.3.221

Prevention of neural tube defects in an urban health district.

D Watson, M Pow, A Ellam, K Costeloe
PMCID: PMC1052297  PMID: 6194239

Abstract

An evaluation of voluntary prenatal screening for neural tube defects with serum alphafetoprotein (s-AFP) is presented. During a three year period, there were 52 fetuses with neural lesions. Of 46 mothers who bore a fetus with an open neural lesion, 25 were detected, of whom 23 agreed to the termination of their pregnancies. An unscreened group of 2331 mothers (17% of all deliveries) produced 14 fetuses with neural tube defects, an incidence of 6.0 per 1000, 1.8 times the incidence (3.3 per 1000) in the screened group. Pitfalls occurring in the assessment of hyper-alphafetoproteinemia included inaccurate gestational dating and allowance for excessive body weight. The results of a robust AFP-NTD screening programme supported in selected cases by ultrasonar visualisation of the spine argue for its continuance in this district.

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grace H. J., Gray R., Conradie J. D. Prenatal detection of neural tube defects by maternal serum alphafetoprotein assay. S Afr Med J. 1981 Aug 22;60(8):319–324. [PubMed] [Google Scholar]
  2. Haddow J. E., Kloza E. M., Knight G. J., Smith D. E. Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester. Clin Chem. 1981 Jan;27(1):133–134. [PubMed] [Google Scholar]
  3. Harris R. Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect. Br Med J. 1980 May 17;280(6225):1199–1202. doi: 10.1136/bmj.280.6225.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Khadempour M. H., Laing I., Gowenlock A. H. An optimised radioimmunoassay for maternal serum alpha1-fetoprotein using polyethylene glycol. Ann Clin Biochem. 1978 Jul;15(4):213–220. doi: 10.1177/000456327801500146. [DOI] [PubMed] [Google Scholar]
  5. Roberts C. J., Hibbard B. M., Evans D. R., Evans K. T., Laurence K. M., Hoole M., Roberts E., Ennis W. P. Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening. Br Med J. 1979 Apr 14;1(6169):981–983. doi: 10.1136/bmj.1.6169.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Watson D., Pow W. Letter: Diagnostic reagents for alpha-fetoprotein. Lancet. 1976 May 8;1(7967):1015–1016. doi: 10.1016/s0140-6736(76)91880-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES